Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2007 1
2008 1
2013 1
2015 1
2016 2
2017 1
2018 1
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological treatment options for cryopyrin-associated periodic syndromes.
Landmann EC, Walker UA. Landmann EC, et al. Expert Rev Clin Pharmacol. 2017 Aug;10(8):855-864. doi: 10.1080/17512433.2017.1338946. Epub 2017 Jun 20. Expert Rev Clin Pharmacol. 2017. PMID: 28586272 Review.
Expert commentary: Due to the success story of current pharmaceutics, the therapeutic options in CAPS are not expected to expand in the near future. Prospective observational studies are needed to confirm long-term efficacy and sustained benefit. ...
Expert commentary: Due to the success story of current pharmaceutics, the therapeutic options in CAPS are not expected to expand in the near …
Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
Yadlapati S, Efthimiou P. Yadlapati S, et al. Mod Rheumatol. 2016;26(1):3-8. doi: 10.3109/14397595.2015.1069459. Epub 2015 Aug 3. Mod Rheumatol. 2016. PMID: 26140469 Review.
Cryopyrin-associated periodic syndromes (CAPS) is a rare group of autoinflammatory disorders that includes familial cold autoinflammatory syndrome or FCAS, Muckle-wells syndrome or MWS, and neonatal-onset multisystem inflammatory disease or NOMID. ...I …
Cryopyrin-associated periodic syndromes (CAPS) is a rare group of autoinflammatory disorders that includes familial cold au …
Molecular and genetic characteristics of hereditary autoinflammatory diseases.
Tunca M, Ozdogan H. Tunca M, et al. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):77-80. doi: 10.2174/1568010053622957. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720239 Review.
There are currently eight hereditary forms of these diseases: Familial Mediterranean fever (FMF), hyperimmunoglobulinemia D with periodic fever syndrome (HIDS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS), familial co …
There are currently eight hereditary forms of these diseases: Familial Mediterranean fever (FMF), hyperimmunoglobulinemia D with periodic fe …
Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia.
Rosengren S, Mueller JL, Anderson JP, Niehaus BL, Misaghi A, Anderson S, Boyle DL, Hoffman HM. Rosengren S, et al. J Allergy Clin Immunol. 2007 Apr;119(4):991-6. doi: 10.1016/j.jaci.2006.12.649. Epub 2007 Feb 22. J Allergy Clin Immunol. 2007. PMID: 17320940 Free PMC article.
BACKGROUND: Familial cold autoinflammatory syndrome (FCAS) is characterized by rash, fever, and arthralgia in response to cold exposure. ...At 16 h, IL-1beta, IL-6, and TNF-alpha were all significantly elevated in FCAS monocytes at 32 degrees C. Increa …
BACKGROUND: Familial cold autoinflammatory syndrome (FCAS) is characterized by rash, fever, and arthralgia in re …
Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood.
Vasse M, Reumaux H, Koné-Paut I, Quartier P, Hachulla E. Vasse M, et al. Clin Exp Rheumatol. 2023 Oct;41(10):2039-2043. doi: 10.55563/clinexprheumatol/bfyb6o. Epub 2023 Mar 9. Clin Exp Rheumatol. 2023. PMID: 36912350 Free article.
We aimed to evaluate the socio-professional impact of CAPS in the long term and the influence of genetic variants in the phenotype. METHODS: We made a multicentre, observational and descriptive study and collected retrospective data from childhood to adulthood, and until t …
We aimed to evaluate the socio-professional impact of CAPS in the long term and the influence of genetic variants in the phenotype. METHODS: …
Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.
Çakan M, Karadağ ŞG, Ayaz NA. Çakan M, et al. Turk J Pediatr. 2020;62(2):167-174. doi: 10.24953/turkjped.2020.02.001. Turk J Pediatr. 2020. PMID: 32419407 Free article.
BACKGROUND AND OBJECTIVES: The aim of this observational retrospective cohort study was to demonstrate indications and response rates of the patients with pediatric rheumatic diseases that used canakinumab. ...Canakinumab led to resolution of attacks in 3 HIDS-MKD cases. T …
BACKGROUND AND OBJECTIVES: The aim of this observational retrospective cohort study was to demonstrate indications and response rates …
Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.
Samson JM, Ravindran Menon D, Vaddi PK, Kalani Williams N, Domenico J, Zhai Z, Backos DS, Fujita M. Samson JM, et al. Front Immunol. 2020 Nov 19;11:584364. doi: 10.3389/fimmu.2020.584364. eCollection 2020. Front Immunol. 2020. PMID: 33329557 Free PMC article.
Here, we used bioinformatics tools, computational modeling, and computational assessments to explore the proteomic consequences of NLRP3 mutations, which potentially drive NLRP3 inflammasome dysregulation. We analyzed 177 mutations derived from familial cold auto …
Here, we used bioinformatics tools, computational modeling, and computational assessments to explore the proteomic consequences of NLRP3 mut …
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.
Walker UA, Tilson HH, Hawkins PN, Poll TV, Noviello S, Levy J, Vritzali E, Hoffman HM, Kuemmerle-Deschner JB; CACZ885D2401 Study Investigators. Walker UA, et al. RMD Open. 2021 May;7(2):e001663. doi: 10.1136/rmdopen-2021-001663. RMD Open. 2021. PMID: 34001647 Free PMC article.
OBJECTIVE: To report the long-term safety and effectiveness of canakinumab, a fully human anti-interleukin 1beta monoclonal antibody, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FC …
OBJECTIVE: To report the long-term safety and effectiveness of canakinumab, a fully human anti-interleukin 1beta monoclonal antibody, in pat …
Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry.
Tilson H, Primatesta P, Kim D, Rauer B, Hawkins PN, Hoffman HM, Kuemmerle-Deschner J, van der Poll T, Walker UA. Tilson H, et al. Orphanet J Rare Dis. 2013 Sep 10;8:139. doi: 10.1186/1750-1172-8-139. Orphanet J Rare Dis. 2013. PMID: 24016338 Free PMC article.
BACKGROUND: The Cryopyrin-Associated Periodic Syndromes (CAPS) are a group of rare hereditary autoinflammatory diseases and encompass Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), and Neonatal Onset Multisystem Inflammato …
BACKGROUND: The Cryopyrin-Associated Periodic Syndromes (CAPS) are a group of rare hereditary autoinflammatory diseases and encompass Fam …
13 results